Atorvastatin Completed Phase 3 Trials for Primary Hyperlipidemia and Mixed Dyslipidemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02189837Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody